Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-29530

Single-particle
3.1 Å
EMD-29530 Deposition: 24/01/2023
Map released: 04/10/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-29530

SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment

EMD-29530

Single-particle
3.1 Å
EMD-29530 Deposition: 24/01/2023
Map released: 04/10/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Severe acute respiratory syndrome coronavirus
Sample: SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Fitted models: 8fxb

Deposition Authors: Park YJ , Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
Neutralization, effector function and immune imprinting of Omicron variants.
PUBMED: 37648855
DOI: doi:10.1038/s41586-023-06487-6
ISSN: 1476-4687
ASTM: NATUAS